Susquehanna International Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-286,300
Closed -$1.4M 12677
2025
Q1
$1.4M Buy
286,300
+244,500
+585% +$1.47M ﹤0.01% 6393
2024
Q4
$349K Buy
41,800
+35,360
+549% +$309K ﹤0.01% 9504
2024
Q3
$67K Sell
6,440
-10,460
-62% -$174K ﹤0.01% 11257
2024
Q2
$331K Sell
16,900
-23,345
-58% -$468K ﹤0.01% 9221
2024
Q1
$1.03M Sell
40,245
-17,960
-31% -$460K ﹤0.01% 6835
2023
Q4
$1.61M Buy
58,205
+35,390
+155% +$2.16M ﹤0.01% 5841
2023
Q3
$1.39M Buy
22,815
+6,975
+44% +$490K ﹤0.01% 5904
2023
Q2
$1.04M Buy
15,840
+3,935
+33% +$288K ﹤0.01% 6571
2023
Q1
$757K Buy
11,905
+7,475
+169% +$854K ﹤0.01% 7528
2022
Q4
$613K Sell
4,430
-2,520
-36% -$355K ﹤0.01% 7331
2022
Q3
$880K Buy
6,950
+975
+16% +$110K ﹤0.01% 6963
2022
Q2
$495K Buy
5,975
+2,785
+87% +$216K ﹤0.01% 8284
2022
Q1
$309K Sell
3,190
-1,295
-29% -$171K ﹤0.01% 10203
2021
Q4
$896K Sell
4,485
-8,292
-65% -$1.96M ﹤0.01% 7580
2021
Q3
$3.16M Sell
12,777
-4,940
-28% -$1.41M ﹤0.01% 4845
2021
Q2
$7.34M Sell
17,717
-12,237
-41% -$4.85M ﹤0.01% 3366
2021
Q1
$11.7M Buy
29,954
+12,430
+71% +$6.12M ﹤0.01% 2534
2020
Q4
$9.82M Buy
17,524
+656
+4% +$416K ﹤0.01% 2514
2020
Q3
$11.8M Buy
16,868
+4,516
+37% +$3.52M ﹤0.01% 1994
2020
Q2
$9.77M Sell
12,352
-2,046
-14% -$1.54M ﹤0.01% 2162
2020
Q1
$8.57M Sell
14,398
-3,111
-18% -$3.03M ﹤0.01% 1917
2019
Q4
$19.9M Sell
17,509
-1,552
-8% -$1.69M 0.01% 1422
2019
Q3
$22.7M Sell
19,061
-6,477
-25% -$9.89M 0.01% 1239
2019
Q2
$42.1M Buy
25,538
+8,662
+51% +$15M 0.02% 789
2019
Q1
$34.4M Sell
16,876
-11,989
-42% -$21.1M 0.01% 839
2018
Q4
$37.1M Buy
28,865
+4,130
+17% +$6.33M 0.01% 717
2018
Q3
$46.8M Sell
24,735
-780
-3% -$1.61M 0.02% 746
2018
Q2
$51.9M Buy
25,515
+2,548
+11% +$5.81M 0.02% 673
2018
Q1
$50.8M Buy
22,967
+5,790
+34% +$14.7M 0.02% 656
2017
Q4
$39.6M Buy
17,177
+5,767
+51% +$11.7M 0.01% 811
2017
Q3
$20.3M Sell
11,410
-3,459
-23% -$4.83M 0.01% 1215
2017
Q2
$20.2M Buy
14,869
+2,641
+22% +$3.19M 0.01% 1166
2017
Q1
$14.4M Sell
12,228
-23,377
-66% -$23.8M 0.01% 1327
2016
Q4
$28.5M Sell
35,605
-486
-1% -$386K 0.01% 823
2016
Q3
$31.7M Buy
36,091
+8,299
+30% +$6.01M 0.02% 730
2016
Q2
$15.6M Sell
27,792
-5,265
-16% -$2.98M 0.01% 1130
2016
Q1
$18.2M Sell
33,057
-494
-1% -$303K 0.01% 1058
2015
Q4
$27.9M Buy
33,551
+4,663
+16% +$4.66M 0.01% 906
2015
Q3
$32M Buy
28,888
+1,721
+6% +$3.14M 0.01% 866
2015
Q2
$59.2M Buy
27,167
+5,929
+28% +$12.1M 0.03% 608
2015
Q1
$33.2M Buy
21,238
+17,556
+477% +$23.2M 0.02% 867
2014
Q4
$4.38M Sell
3,682
-3,119
-46% -$2.08M ﹤0.01% 3089
2014
Q3
$3.16M Buy
6,801
+2,817
+71% +$1.3M ﹤0.01% 3808
2014
Q2
$1.99M Buy
+3,984
New +$1.28M ﹤0.01% 4676

Other funds holding BLUE

Susquehanna International Group's BLUE Position: Q2 2025 in Review

Susquehanna International Group sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 56,588 shares — an estimated $276K sold.

Susquehanna International Group first reported a position in BLUE in Q1 2014 and held it in 44 quarters. The position peaked at $53M in Q2 2018. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.

  • Susquehanna International Group reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 56,588 bluebird bio shares in Q2 2025, an estimated $276K.
  • Susquehanna International Group first reported a position in bluebird bio in Q1 2014 and held it in 44 quarters.
  • Susquehanna International Group's bluebird bio position peaked at $53M in Q2 2018.
  • 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.